A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).
Kodera Y, Ito S, Mochizuki Y, Fujitake S, Koshikawa K, Kanyama Y, Matsui T, Kojima H, Takase T, Ohashi N, Fujiwara M, Sakamoto J, Akimasa N; Chubu Clinical Cancer Group.
Kodera Y, et al.
Anticancer Res. 2007 Jul-Aug;27(4C):2667-71.
Anticancer Res. 2007.
PMID: 17695430
Free article.
Clinical Trial.